[HTML][HTML] Nintedanib in progressive fibrosing interstitial lung diseases
Background Preclinical data have suggested that nintedanib, an intracellular inhibitor of
tyrosine kinases, inhibits processes involved in the progression of lung fibrosis. Although the …
tyrosine kinases, inhibits processes involved in the progression of lung fibrosis. Although the …
Interstitial lung disease in systemic sclerosis: a simple staging system
…, TJ Corte, CR Sander, J Ratoff, A Devaraj… - American journal of …, 2008 - atsjournals.org
Rationale: In interstitial lung disease complicating systemic sclerosis (SSc-ILD), the optimal
prognostic use of baseline pulmonary function tests (PFTs) and high-resolution computed …
prognostic use of baseline pulmonary function tests (PFTs) and high-resolution computed …
Respiratory follow-up of patients with COVID-19 pneumonia
…, SL Barratt, R Condliffe, SR Desai, A Devaraj… - Thorax, 2020 - thorax.bmj.com
The COVID-19 pandemic has led to an unprecedented surge in hospitalised patients with
viral pneumonia. The most severely affected patients are older men, individuals of black and …
viral pneumonia. The most severely affected patients are older men, individuals of black and …
European position statement on lung cancer screening
M Oudkerk, A Devaraj, R Vliegenthart… - The Lancet …, 2017 - thelancet.com
Lung cancer screening with low-dose CT can save lives. This European Union (EU) position
statement presents the available evidence and the major issues that need to be addressed …
statement presents the available evidence and the major issues that need to be addressed …
Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations
…, SJ Wort, T Xu, SPG Padley, A Devaraj… - American journal of …, 2020 - atsjournals.org
Rationale: Clinical and epidemiologic data in coronavirus disease (COVID-19) have accrued
rapidly since the outbreak, but few address the underlying pathophysiology. Objectives: To …
rapidly since the outbreak, but few address the underlying pathophysiology. Objectives: To …
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised …
…, KR Flaherty, KK Brown, Y Inoue, A Devaraj… - The lancet Respiratory …, 2020 - thelancet.com
Background The INBUILD trial investigated the efficacy and safety of nintedanib versus
placebo in patients with progressive fibrosing interstitial lung diseases (ILDs) other than …
placebo in patients with progressive fibrosing interstitial lung diseases (ILDs) other than …
[PDF][PDF] Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease
Some patients hospitalized with acute COVID-19 suffer respiratory symptoms that persist for
many months. We delineated the immune-proteomic landscape in the airways and …
many months. We delineated the immune-proteomic landscape in the airways and …
CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge
B Vijayakumar, J Tonkin, A Devaraj, KEJ Philip… - Radiology, 2022 - pubs.rsna.org
Background Data on the long-term pulmonary sequelae in COVID-19 are lacking. Purpose
To assess symptoms, functional impairment, and residual pulmonary abnormalities on serial …
To assess symptoms, functional impairment, and residual pulmonary abnormalities on serial …
[HTML][HTML] The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
…, DR Baldwin, KE Brain, A Devaraj… - Health technology …, 2016 - ncbi.nlm.nih.gov
BACKGROUND Lung cancer kills more people than any other cancer in the UK (5-year
survival< 13%). Early diagnosis can save lives. The USA-based National Lung Cancer …
survival< 13%). Early diagnosis can save lives. The USA-based National Lung Cancer …
Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination
Purpose To test the reliability of potentially new computed tomographic (CT) indicators of
pulmonary hypertension (PH) and to establish whether a combination of CT and …
pulmonary hypertension (PH) and to establish whether a combination of CT and …